Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs031180316Active, not recruiting
Randomised, open-label trial of pramipexole in tardive dystonia (TD) (2 arms), sponsored by Chiba University Hospital. Primary endpoint: Burke-Fahn-Marsden Dystonia Rating Scale at week 16. Started Feb 2015; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs031180316.